Public-registry site landscape for NCT07607483, a Healthy study sponsored by Eli Lilly and Company. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07607483 (registry record) |
| Sponsor | Eli Lilly and Company |
| Condition(s) | Healthy |
| Phase | PHASE1 |
| Listed sites | 2 |
| Site countries | United States |
At Fortrea Clinical Research Unit — one of the facilities listed on this trial — 11 other studies are actively recruiting Healthy patients at the same facility (public registry, as of August 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07607483 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →